Latest News


New Treatment

Ground breaking approach to emergency care in NSW to be tested.

New funding will see a large-scale project launched across NSW to significantly improve patient outcomes and experiences in Emergency Departments. Chief investigator and Kolling Institute researcher Professor Margaret Fry said more than $2.8 million will be invested in the EPIC-START program, giving patients better access to early evidence-based treatment pathways. 30 Emergency Departmen.....
Read more

Category: New Treatment, Research Excellence

Australia to introduce ground breaking technology to target debilitating Mito disease.

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faul.....
Read more

Category: Neuroscience and Pain Research, New Treatment, World-leading technology

Researchers identify the best way to ease chronic pain.

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 p.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Researchers develop new program to reduce medication burden  .

A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such as falls, .....
Read more

Category: New Treatment, Research Excellence

Game-changing research partnership to ease musculoskeletal burden.

An important new partnership has been formed to dramatically improve care for musculoskeletal conditions by speeding up the translation of research to clinical practice. The Northern Sydney Local Health District has joined with the University of Sydney and Sydney Local Health District to create Sydney Musculoskeletal Health which will link researchers from across the University with clin.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

World Spine Day: Kolling researchers challenging old concepts to improve care.

To mark World Spine Day on October 16, the Back Pain Research team at the Kolling Institute is urging those who experience the condition to adopt the latest advice and keep moving. Spinal pain is extremely common, affecting around 800 million people globally. The condition compromises social, family and work activities, and is the main reason Australians retire involuntarily. The lower b.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Technology to deliver support to those with back pain during the pandemic.

While the COVID-19 pandemic is interrupting access to some healthcare services, an innovative approach may hold the key to support for those with low back pain. Researchers at the University of Sydney and the Kolling Institute have launched a study to measure the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Manue.....
Read more

Category: Musculoskeletal Research, New Treatment

Age and sex influence the adverse effects of multiple medications.

There are calls for a carefully-considered, tailored approach to the prescription of multiple medicines with new research finding a person’s age and sex influence the impact of multiple medications. More than half of older Australians take five or more regular medications, with the higher number of medications directly linked to a higher chance of adverse reactions, like falls, confusion.....
Read more

Category: Neuroscience and Pain Research, New Treatment

First large-scale trial of stem cell therapy for knee osteoarthritis launched.

Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor Hunter, the Florance and Cope .....
Read more

Category: Musculoskeletal Research, New Treatment

A simple mix of treatments holds the key to better hand function.

The base of our thumb may just be a small part of our hand, but osteoarthritis in that area can have a significant impact, making the simplest tasks difficult. The condition especially affects post-menopausal women, with figures indicating up to a third of women over 70 have this type of osteoarthritis. Increasing numbers of people are experiencing the condition, and yet current treatme.....
Read more

Category: Musculoskeletal Research, New Treatment